A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
Clinical trial NCT03819465 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03819465
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2023-05-23
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.